Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E C Cole

Showing results (21-30 of 111) with videos related to

Pageof 12
Sort By:
European Journal of Pediatrics|November 9, 2002
Severe cleidocranial dysplasia can mimic hypophosphatasiaSheila Unger, Etienne Mornet, Stefan Mundlos, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 23, 2011
Vitamin D-related genetic variants, interactions with vitamin D exposure, and breast cancer risk among Caucasian women in OntarioLaura N Anderson, Michelle Cotterchio, David E C Cole, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 25, 2014
G protein-coupled receptor accessory proteins and signaling: pharmacogenomic insightsMiles D Thompson, David E C Cole, Pedro A Jose, et al.
Supportive Cancer Therapy|July 18, 2008
Urinary N-telopeptide is a rapid predictor of response to and palliative benefit from bisphosphonate therapy in patients with metastatic breast cancerChristine Simmons, Reuben J Broom, David E C Cole, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2008
G protein-coupled receptors disrupted in human genetic diseaseMiles D Thompson, Maire E Percy, W McIntyre Burnham, et al.
Clinical Biochemistry|November 26, 2003
An improved assay for plasma methylmalonic acid using chemical ionization gas chromatography mass spectrometryMehrdad Yazdanpanah, Pak Cheung Chan, Jovan Evrovski, et al.
Human Mutation|August 21, 2008
Glial cells missing-2 (GCM2) transactivates the calcium-sensing receptor gene: effect of a dominant-negative GCM2 mutant associated with autosomal dominant hypoparathyroidismLucie Canaff, Xiang Zhou, Irina Mosesova, et al.
The Journal of Clinical Endocrinology and Metabolism|February 4, 2011
Neonatal hyperparathyroidism with a heterozygous calcium-sensing receptor (CASR) R185Q mutation: clinical benefit from cinacalcetChristina M S Reh, Geoffrey N Hendy, David E C Cole, et al.
Human Mutation|July 9, 2004
CASRdb: calcium-sensing receptor locus-specific database for mutations causing familial (benign) hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemiaSvetlana Pidasheva, Lilia D'Souza-Li, Lucie Canaff, et al.
Obstetrics and Gynecology|February 3, 2005
Greater maternal weight and the ongoing risk of neural tube defects after folic acid flour fortificationJoel G Ray, Philip R Wyatt, Marian J Vermeulen, et al.
Pageof 12

Showing results (21-30 of 111) with videos related to

Sort By:
Pageof 12
European Journal of Pediatrics|November 9, 2002
Severe cleidocranial dysplasia can mimic hypophosphatasiaSheila Unger, Etienne Mornet, Stefan Mundlos, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 23, 2011
Vitamin D-related genetic variants, interactions with vitamin D exposure, and breast cancer risk among Caucasian women in OntarioLaura N Anderson, Michelle Cotterchio, David E C Cole, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 25, 2014
G protein-coupled receptor accessory proteins and signaling: pharmacogenomic insightsMiles D Thompson, David E C Cole, Pedro A Jose, et al.
Supportive Cancer Therapy|July 18, 2008
Urinary N-telopeptide is a rapid predictor of response to and palliative benefit from bisphosphonate therapy in patients with metastatic breast cancerChristine Simmons, Reuben J Broom, David E C Cole, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2008
G protein-coupled receptors disrupted in human genetic diseaseMiles D Thompson, Maire E Percy, W McIntyre Burnham, et al.
Clinical Biochemistry|November 26, 2003
An improved assay for plasma methylmalonic acid using chemical ionization gas chromatography mass spectrometryMehrdad Yazdanpanah, Pak Cheung Chan, Jovan Evrovski, et al.
Human Mutation|August 21, 2008
Glial cells missing-2 (GCM2) transactivates the calcium-sensing receptor gene: effect of a dominant-negative GCM2 mutant associated with autosomal dominant hypoparathyroidismLucie Canaff, Xiang Zhou, Irina Mosesova, et al.
The Journal of Clinical Endocrinology and Metabolism|February 4, 2011
Neonatal hyperparathyroidism with a heterozygous calcium-sensing receptor (CASR) R185Q mutation: clinical benefit from cinacalcetChristina M S Reh, Geoffrey N Hendy, David E C Cole, et al.
Human Mutation|July 9, 2004
CASRdb: calcium-sensing receptor locus-specific database for mutations causing familial (benign) hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemiaSvetlana Pidasheva, Lilia D'Souza-Li, Lucie Canaff, et al.
Obstetrics and Gynecology|February 3, 2005
Greater maternal weight and the ongoing risk of neural tube defects after folic acid flour fortificationJoel G Ray, Philip R Wyatt, Marian J Vermeulen, et al.
Pageof 12